拓小八
Lv61
2620 积分
2022-01-17 加入
-
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
1个月前
已完结
-
BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy
3个月前
已完结
-
The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective
3个月前
已完结
-
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
3个月前
已完结
-
Exploring the next generation of antibody–drug conjugates
3个月前
已完结
-
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
3个月前
已完结
-
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
3个月前
已完结
-
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
3个月前
已完结
-
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
3个月前
已完结
-
Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class
4个月前
已完结